# Mercaptopurine

NDC: 0378-3547
Generic name: mercaptopurine
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20050701
Marketing ended: 20260531
FDA application: ANDA040594

## Active ingredients

- MERCAPTOPURINE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-3547"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-3547
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15904472-4c32-4224-95d3-eb131a7ff9c8